Purchases and Sales Made in Q4 2024 in Anebulo Pharmaceuticals, Inc. (ANEB)
This table provides information about the institutional ownership of Anebulo Pharmaceuticals, Inc. (ANEB) during Q4 2024. The information is specifically focused on institutions that hold shares of Anebulo Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
22 Nw, LP
Seattle, WA |
BUY
|
- |
10.1M+ 188.23% |
$10M - $20M
|
15.5M
$19.5M
|
|
|
Feb 14, 2025
Q4 2024
|
Mangrove Partners
New York, NY |
BUY
|
- |
2.53MNew |
$2.5M - $5M
|
2.53M
$3.18M
|
|
|
Feb 14, 2025
Q4 2024
|
Nantahala Capital Management, LLC
New Canaan, CT |
BUY
|
- |
2.53M+ 494.11% |
$2.5M - $5M
|
3.04M
$3.83M
|
|
|
Feb 07, 2025
Q4 2024
|
King Luther Capital Management Corp
Fort Worth, TX |
BUY
|
- |
59.7KNew |
$59.1K - $118K
|
59.7K
$75.2K
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
20.8K+ 5.2% |
$20.6K - $41.1K
|
420K
$529K
|
|
|
Feb 12, 2025
Q4 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
3.55K+ 4.04% |
$3.52K - $7.03K
|
91.3K
$115K
|
|
|
Feb 13, 2025
Q4 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
632+ 23.46% |
$626 - $1.25K
|
3.33K
$4.19K
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-142- 0.09% |
$141 - $281
|
158K
$199K
|
|
|
Feb 14, 2025
Q4 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-142- 0.75% |
$141 - $281
|
18.8K
$23.7K
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
SELL
|
- |
-738- 96.72% |
$731 - $1.46K
|
25
$31.5
|
|
|
Jan 16, 2025
Q4 2024
|
Lvw Advisors, LLC
|
SELL
|
- |
-8.52K- 1.33% |
$8.44K - $16.9K
|
633K
$797K
|